Journals / Türk Oftalmoloji Dergisi / 2007 / Cilt: 37 - Sayı: 2

Histopathological and epidemiological evaluation of eyelid masses

Göz kapağı kitlelerinin histopatolojik ve epidemiyolojik değerlendirilmesi

Pages
84–92
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The most frequently seen malign eyelid tumor was basal cell carcinoma (BCC) 30 masses, (76.92 %), and the others were squamous cell carcinoma (SCC), 6 (15.40 %), malig­nant melanoma (MM) 1 mass (2.56%), sebaceous gland carcinoma (SGC) 1 (2.56%), Non Hodgkin Lymphoma (NHL) 1 mass (2.56%), respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pur-pose: To investigate the clinical, histopathological and epidemiological features of the masses of the eyelids.
📊
Key Findings & Data:Material and Methods: 326 eyelid lesions of 281 patients applied to Dr.
💡
Conclusion & Impact:The most frequently seen malign eyelid tumor was basal cell carcinoma (BCC) 30 masses, (76.92 %), and the others were squamous cell carcinoma (SCC), 6 (15.40 %), malig­nant melanoma (MM) 1 mass (2.56%), sebaceous gland carcinoma (SGC) 1 (2.56%), Non Hodgkin Lymphoma (NHL) 1 mass (2.56%), respectively.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Pur-pose: To investigate the clinical, histopathological and epidemiological features of the masses of the eyelids. Material and Methods: 326 eyelid lesions of 281 patients applied to Dr. Lutfi Kirdar Kar­tal Training and Research Hospital, 1st Eye clinic complaining of eyelid lesion between 1997-2005 were evaluated according to the localizations and the number of lesions, clinical diagno­sis, histopathological diagnosis and sex distribution retrospectively and prospectively. Results: 130 (%46.26) of 281 patients were male and 151 (%53.74) were female. The age of the patients ranged between 2 and 80 years (mean 48.2) and the mean follow up period was 32.4 months (between 1-101 months). Histopathological evaluation revealed that 287 (%88.1) of 326 lesions were benign and 39 (%11.9) were malign. The most frequently seen benign mas­ses were chalazion 94 masses (32.76%), squamous papilloma 46 masses, (16.02%), intradermal nevus 22 masses (7.66%X,xanthelasma 20 masses (6.96%), seborrheic keratosis 16 masses, (5.57%). The most frequently seen malign eyelid tumor was basal cell carcinoma (BCC) 30 masses, (76.92 %), and the others were squamous cell carcinoma (SCC), 6 (15.40 %), malig­nant melanoma (MM) 1 mass (2.56%), sebaceous gland carcinoma (SGC) 1 (2.56%), Non Hodgkin Lymphoma (NHL) 1 mass (2.56%), respectively.

Özet

Amaç: Gözkapaklarında görülen kitlelerin klinik ve epidemiyolojik özelliklerini incele­mek. Gereç ve Yöntem: 1996-2005 tarihleri arasında Dr. Lütfi Kırdar Kartal Eğitim ve Araştır­ma Hastanesi 1. Göz Kliniğine göz kapağında kitle şikayeti ile başvuran 281 hastanın 326 ka­pak lezyonu, yerleşim yeri, kitle sayısı, klinik ön tanı, histopatolojik tanı ve cinsiyete göre dağı­lım açısından, retrospektif ve prospektif olarak değerlendirildi. Bulgular: 281 hastanın 130'u erkek (%46.26), 151'i (%53.74) kadındı. Yaşları 2 ile 80 yıl (ortalama 48.2), arasında değişen hastalar ortalama 32.4 ay (1-101) takip edildi. Histopatolojik değerlendirme sonucunda 326 lezyonun 287'si (%88.1) iyi huylu, 39'u (%11.9) kötü huylu ola­rak tanımlandı. En sık görülen iyi huylu kapak kitleleri; şalazyon (94 kitle, % 32.76), squamoz papillom (46 kitle,%. 16.02), intradermal nevüs (22 kitle, %7.66), ksantelesma (20 kitle, %6.96), seboreik keratoz (16 kitle, %.5.57); en sık görülen kötü huylu kapak tümörü bazal hüc­reli karsinom (BHK) (30 kitle, %.76.92) idi. Bunu sırasıyla skuamöz hücreli karsinom (SHK) 6 (%15.40), malign melanom (MM) 1, (%2.56), sebase bez karsinomu (SBK) 1 (%2.56), Non Hodgkin Lenfoma (NHL), 1 (%2.56) izlemekteydi. Sonuç: Göz kapaklarında lokalize olan lezyonların çoğu iyi huylu olmakla ve eksizyonla tedavi edilebilmekle beraber, göz kapaklarında görülen her türlü lezyonda maligniteler akla ge­tirilmeli ve biyopsi ile tanı kesinleştirilmelidir.

🔖

Cite This Article

TAŞKIRAN, A., AKÇAY, L., DOĞAN, Ö. K., KARADĞ, O., ÖZGÜR, Ö. (2022). Histopathological and epidemiological evaluation of eyelid masses. Türk Oftalmoloji Dergisi, Cilt: 37 - Sayı: 2, 84–92. https://ajindex.com/articles/638644

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ten Seldman REJ, Helwig EB: Histological typing of skin tumors. Geneva: World Health Organization, 1974; 48-49 World Health Organization. International classification of diseases. Manual of the international statistical classifica­ tion of disease, injuries, and causes of death. 9th revision, Vol. 1. Geneva, Switzerland: World Health Organization, 1977
  2. Yalaz M, Varınlı S, Varınlı İ: Oftalmik tümör ve tümör benzeri lezyonların klinikopatolojik değerlendirme- si,T.Oft.Gaz. 1990;20; 462-466
  3. Özkılıç E, Peksayar G: Kapak tümörlerinin epidemiyolo­ jik açıdan değerlendirilmesi. T Oft Gaz. 2003; 33(4/1): 631-640 Tesluk GC: Eyelid lesions: Incidence and comparison of benign and malignant lesions. Ann Ophthalmol 1985; 17:704-707 CE Margo: Eyelid tumors: Accuracy of clinical diagnosis. Am J Ophthalmol. 1999; 128(5):635-636
  4. Aurora A, Blodi F: Lesions of the eyelids.A clinicopatho- logical study. Surv. Ophthal 1970; 15:94-104
  5. Abdi U, Tyagi Nmaneshwari V, et al: Tumors of the eye­ lid: a clinicopathologic study. J Indian Med Assoc 1996; 94: 405-409
  6. SM Chang, YH Lai, J Huang, MY Su, HZ Wang, and YT Liu: Eyelid tumors in southern Taiwan: A 5-year survey from a medical university. Kaohsiung J Med Sci. 2003; 19(11):549-554
  7. AH Deshpande, MM Munshi. Fine needle capillary samp­ ling of eyelid masses. A study of 70 cases: Acta Cytol 2003; 7(3): 349-358
  8. Sao-Bing Lee, Seang-Mei Saw, Kah-Guan Au Eong, Tat- Keong Chan, Hin-Peng Lee: Incidence of eyelid cancers in Singapore from 1968 to 1995. Br J Ophthalmol 1999;83:595-597
  9. Sanjay Kumar Daulat Thakur, Shatrughan Prasad Sah, Mamta Lakhey and Badri Prasad Badhu. Primary malig­ nant tumours of eye and adnexa in Eastern Nepal. Clin Experimental Ophthalmol 2003;31(5):415-417
  10. Zengin N, Karakurt A: Göz kapağının malign tümörleri; Türkiye Klinikleri Oftalmoloji. 1993;3:307-311
  11. Liu CH, Ma L: The clinical features and surgical results of malignant eyelid tumors. Chang Gung Med J. 2001; 24(2):84-90
  12. Swanson MW, Cloud G: A retrospective analysis of pri­ mary eye cancer at the University of Alabama 1958-1988. Part 2: Eyelid tumors. J Am Optom Assoc. 1991; 62(11):820-823
  13. Francis IC, Benecke PS, Kappagoda MB: A ten year hos­ pital survey of eyelid cancer. Aust J Ophthalmol 1984; 12(2):121-127
  14. Abe M, Ohnishi Y, Hara Y, et al: Malignant tumour of the eyelid- clinical survey during a 22-year period. Jpn J Ophthalmol 1983;27:175-184
  15. Soysal H. G, Albayrak A: Göz kapaklarının primer malig­ nant tümörleri. T. Oft.Gaz 2001;31:370-377
  16. Curtis EM, Zuber DM: M